Schedule 13G ownership disclosure

OvaScience, Inc.

Security class unavailable · CUSIP: 69014Q101

Event date: 2015-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
1.5000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000093751-16-000258
Form type
SC 13G/A
Filer
Tempest Therapeutics, Inc.
CIK
CIK 1544227
Filed
Jan 11, 2016
Reporting period
Dec 31, 2015
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub